CLINUVEL competitorsClear all

CLINUVEL's top competitors include Athersys, Reata Pharmaceuticals, Otonomy and Regulus Therapeutics.
CLINUVEL
CLINUVEL
CLINUVEL PHARMACEUTICALS is a company that provides drugs for the treatment of severe skin disorders.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date
Founding Date
2001
Founding Date
1995
Founding Date
2002
Founding Date
2008
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Melbourne, AU HQ
Dublin, IE
Singapore, SG
Baar, CH
Leatherhead, GB
Burlingame, US
Locations
Cleveland, US HQ
Canton, US
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
San Diego, US HQ
Locations
San Diego, US HQ
Employees
Employees
N/A
Employees
8311% increase
Employees
22079% increase
Employees
49
Employees
2462% decrease
Valuation ($)
Valuation ($)
808.2 m
Valuation ($)
570.7 m
Valuation ($)
5.2 b
Valuation ($)
118.8 m
Valuation ($)
23 m
Twitter followers
Twitter followers
1.3 k
Twitter followers
1.9 k
Twitter followers
920
Twitter followers
228
Twitter followers
763
Number of tweets (last 30 days)
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.2
Average likes per tweet (last 30 days)
39.6
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
96.3%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
427972
Alexa Website Rank
322595
Alexa Website Rank
229923
Alexa Website Rank
476422
Alexa Website Rank
395368
Employee Rating
Employee Rating
4
Employee Rating
5
Employee Rating
4
Employee Rating
4.3
Employee Rating
3.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$5.6m (FY, 2019)
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$600k (FY, 2019)
Revenue (est.)
$6.8m (FY, 2019)
Net income
Net income
N/A
Net income
($44.6m) (FY, 2019)
Net income
($290.2m) (FY, 2019)
Net income
($44.7m) (FY, 2019)
Net income
($18.6m) (FY, 2019)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
240 (FY, 2016)
Patents Issued
88 (FY, 2016)
Patents Issued
300 (FY, 2016)
Patents Pending
Patents Pending
N/A
Patents Pending
N/A
Patents Pending
280 (FY, 2016)
Patents Pending
115 (FY, 2016)
Patents Pending
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 9m
Total funding raised
$ 468.9m
Total funding raised
$ 153.4m
Total funding raised
$ 10m
For sources of this data, please see the company profile

View company profiles

Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company